OR WAIT null SECS
March 02, 2015
Scientists and industry experts seek effective preventive therapies to combat global disease.
The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.
February 17, 2015
The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high United States revenues to fund biopharmaceutical R&D.
February 02, 2015
The 2016 White House Budget proposes a change to the data exclusivity period for biologics and the authority to influence drug pricing.
New guidelines focused on the materials of construction in biologic therapy packaging will help vendors prepare comprehensive extractable and leachable testing strategies.
January 23, 2015
Government and industry efforts to address manufacturing challenges move Ebola vaccine candidates into larger clinical trials.
December 17, 2014
FDA drug approvals are up in 2014 with biologics drugs representing more than 25% of FDA approvals to date.
December 15, 2014
Baxter announced that it had entered into an agreement to sell its Vero cell technology and related assets to Nanotherapeutics.
December 11, 2014
US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.
December 04, 2014
No evidence that Fluad vaccine caused deaths in Italy, says EMA.